LIVERMORE, CA --
FREMONT, Calif., April 30, 2014 (GLOBE NEWSWIRE) -- Oplink Communications, Inc. (Nasdaq:OPLK) , a leading provider of optical communication components, intelligent modules and subsystems, today reported its financial results for its third quarter of fiscal year 2014, ended March 30, 2014.
Record Low Costs Lead to 39% Increase in Net Cash from Operations to $81
(All figures are in US dollars unless otherwise indicated)
VANCOUVER , April 30, 2014 /PRNewswire/ - New Gold Inc. ("New Gold") (TSX:NGD)
and (NYSE MKT:NGD) today announces first quarter 2014 operational and
Revenue Increases 66% Over First Quarter 2013 SAN FRANCISCO , April 30, 2014 /PRNewswire/ -- Yelp Inc. (NYSE: YELP) , the company that connects consumers with great local businesses, today announced financial results for the first quarter ended March 31, 2014 .
CAMBRIDGE, Mass., April 30, 2014 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) , a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will webcast its presentation at three upcoming investor conferences.
RALEIGH, N.C., April 30, 2014 (GLOBE NEWSWIRE) -- Triangle Capital Corporation (NYSE:TCAP) ("Triangle" or the "Company"), a leading provider of capital to lower middle market companies, announced today that it closed a $12.5 million investment in AGM Automotive ("AGM"). Headquartered in Troy, Michigan, AGM is a global supplier of automotive interior trim, lighting, and electrical components.
Achieves Positive Cash Flow on Strong Revenue Growth
SUNNYVALE, Calif., April 30, 2014 (GLOBE NEWSWIRE) -- Accuray Incorporated (Nasdaq:ARAY) announced today financial results for the third fiscal quarter and nine months ended March 31, 2014.
SPOKANE, Wash., April 30, 2014 (GLOBE NEWSWIRE) -- Red Lion Hotels Corporation (NYSE:RLH) , a western U.S. based owner, operator and franchisor of midscale hotels, today announced its results for the first quarter ended March 31, 2014.
-Endometriosis Phase III Violet Petal Study Completes Screening- -Tardive Dyskinesia Phase III Initiation Planned for Second Half of 2014- -Over $270 Million to Fund Clinical Pipeline-
SAN DIEGO , April 30, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced its financial results for the quarter ended March 31 , 2014.
Reported revenues of $580.1 million, a 3% increase over the previous quarter and a 12% increase over the same quarter last year Increased 2014 annual guidance of revenues to be greater than $2,395.0 million and adjusted EBITDA to be greater than $1,105.0 million
REDWOOD CITY, Calif.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.